Your trusted destination for CME, CPD & Medical Education across the Middle East.
The First Pediatric Hematology–Oncology Conference – Asir focuses on the latest advances in diagnosing and managing pediatric blood disorders and cancers. It brings together specialists to discuss current treatment approaches, multidisciplinary care, and strategies for improving outcomes in children with hematological and oncological conditions.
The First Pediatric Hematology–Oncology Conference – Asir brings together leading specialists to share the latest advances in the diagnosis, treatment, and management of pediatric hematological and oncological disorders. The conference covers key topics including pediatric leukemia and solid tumors, sickle cell disease, thalassemia, bone marrow failure, hemophilia, neuro-oncology, transfusion medicine, and supportive and palliative care. Through expert lectures and multidisciplinary discussions, participants will explore current clinical approaches, emerging therapies, and best practices in pediatric hematology and oncology. The program provides healthcare professionals with an opportunity to enhance their knowledge, exchange clinical experiences, and improve the quality of care provided to children with blood disorders and cancer. The conference is designed for pediatricians, hematologists, oncologists, pharmacists, nurses, and other healthcare professionals involved in pediatric hematology and oncology.
Current practices and future directions for gene therapy in transfusion-dependent patients.
Diagnosis, management, and emerging treatments for bone marrow failure in children.
Latest clinical approaches to managing Hemophagocytic Lymphohistiocytosis.
Advancements in the treatment and management of pediatric hemophilia.
Evaluating and treating complex vascular anomalies and thrombotic events in children.
Best practices and protocols for safe and effective transfusion support.
Diagnostic challenges and therapeutic strategies for AIHA.
The role of genetic testing in guiding precision medicine in pediatric oncology.
New techniques and safety protocols in pediatric radiotherapy.
Recent developments in the management of Acute Lymphoblastic Leukemia.
Mitigation strategies and supportive care for chemotherapy-induced toxicities.
Emerging therapies and long-term outcomes for neuroblastoma patients.
Multidisciplinary treatment strategies for pediatric brain and bone tumors.
Rapid identification and response to critical oncologic emergencies.
Enhancing patient comfort and safety through effective pain and neutropenia management.
This conference is accredited by the Saudi Commission for Health Specialties (SCFHS) for 15 CME hours (Accreditation No: ACA-20260002545).
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
